L Agarwal
Overview
Explore the profile of L Agarwal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma S, Agarwal L, Saxena R
Indian J Microbiol
. 2012 Oct;
47(2):132-8.
PMID: 23100655
Statistically based experimental design was employed for the optimization of fermentation conditions for maximum production of enzyme tannase from Aspergillus niger. Central composite rotatable design (CCRD) falling under response surface...
2.
Bhattacharjee H, Ramman T, Agarwal L, Nain M, Thomas S
Ann Trop Med Parasitol
. 2011 Nov;
105(6):455-61.
PMID: 22117855
No abstract available.
3.
Benjamin E, Flanagan J, Schilling A, Chang H, Agarwal L, Katz E, et al.
J Inherit Metab Dis
. 2009 Apr;
32(3):424-40.
PMID: 19387866
Fabry disease is an X-linked lysosomal storage disorder caused by mutations in the gene encoding alpha-galactosidase A (alpha-Gal A), with consequent accumulation of its major glycosphingolipid substrate, globotriaosylceramide (GL-3). Over...
4.
Darji P, Vijayaraghavan R, Thiagarajan C, Sharma R, Subbarao B, Pishardy R, et al.
Transplant Proc
. 2008 Sep;
40(7):2262-7.
PMID: 18790208
Objective: The objective of this prospective study was to evaluate the effect of conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) in renal transplant recipients with gastrointestinal tract...
5.
Agarwal L, Isar J, Meghwanshi G, Saxena R
J Appl Microbiol
. 2006 May;
100(6):1348-54.
PMID: 16696683
Aim: Development and optimization of an efficient and inexpensive medium for succinic acid production by Escherichia coli under anaerobic conditions. Methods And Results: Initially, 0.8 gl(-1) of succinic acid was...
6.
Geddes C, Prasad G, Agarwal L, Reich H, Wei C, Cole E
Kidney Int
. 2000 Mar;
57(3):1206-7.
PMID: 10720976
No abstract available.
7.
Liverton N, Butcher J, Claiborne C, Claremon D, Libby B, Nguyen K, et al.
J Med Chem
. 1999 Jun;
42(12):2180-90.
PMID: 10377223
Novel potent and selective diarylimidazole inhibitors of p38 MAP (mitogen-activated protein) kinase are described which have activity in both cell-based assays of tumor necrosis factor-alpha (TNF-alpha) release and an animal...
8.
de Laszlo S, Visco D, Agarwal L, Chang L, Chin J, Croft G, et al.
Bioorg Med Chem Lett
. 1999 Jan;
8(19):2689-94.
PMID: 9873604
Investigation of furans, pyrroles and pyrazolones identified 3-pyridyl-2,5-diaryl-pyrroles as potent, orally bioavailable inhibitors of p38 kinase. 3-(4-pyridyl-2-(4-fluoro-phenyl)-5-(4-methylsulfinylphenyl)-pyrrol e (L-167307) reduces secondary paw swelling in the rat adjuvant arthritis model: ID50...
9.
Fletcher D, Agarwal L, Chapman K, Chin J, Egger L, Limjuco G, et al.
J Interferon Cytokine Res
. 1995 Mar;
15(3):243-8.
PMID: 7584670
A potent, reversible, tetrapeptide inhibitor of interleukin-1 beta converting enzyme (ICE), L-709,049, has been shown to suppress the in vitro production of mature IL-1 beta. We now report that this...
10.
Stolk J, Rudolphus A, Davies P, Osinga D, Dijkman J, Agarwal L, et al.
J Pathol
. 1992 Jul;
167(3):349-56.
PMID: 1517904
The aim of this study was to determine whether lipopolysaccharide-induced elastase release from recruited neutrophils in the hamster lung would induce emphysema, measured by mean linear intercept (Lm) and bronchial...